PaulErnestJenningsMD

PubMed

• 1 citations
  Paget's disease of the skull causing hyperprolactinemia and erectile dysfunction: a case report
  Rachel Hepherd, Paul Jennings> ;Journal of Medical Case Reports. 2008 Jul 18
• The biological variation of sex hormone-binding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance.
  Jayagopal, V., Kilpatrick, E.S., Jennings, P.E., Holding, S., Hepburn, D.A., Atkin, S.L.> ;Diabetes Care. 2004 Jan
• Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism.
  Jayagopal, V., Keevil, B.G., Atkin, S.L., Jennings, P.E., Kilpatrick, E.S.> ;Clin Chem. 2003 Apr
• Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes.
  Jayagopal, V., Kilpatrick, E.S., Jennings, P.E., Hepburn, D.A., Atkin, S.L.> ;Diabetes Care. 2002 Nov
• Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.
  Jayagopal, V., Albertazzi, P., Kilpatrick, E.S., Howarth, E.M., Jennings, P.E., Hepburn, D.A., Atkin, S.L.> ;Diabetes Care. 2002 Oct
• 38 citations
  Vascular benefits of gliclazide beyond glycemic control.
  Paul E. Jennings> ;Metabolism. 2000 Oct 1
• 10 citations
  From hemobiology to vascular disease: A review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease
  Paul E. Jennings> ;Journal of Diabetes and Its Complications. 1994 Oct 1
• 7 citations
  The potential of gliclazide, a sulphonylurea to influence the oxidative processes within the pathogenesis of diabetic vascular disease.
  Paul Jennings> ;Advances in Experimental Medicine and Biology. 1994 Jan 1
• Dissociation of changes in sodium transport in erythrocytes from changes in blood pressure.
  Wilkins, M. R., Jennings, P. E., West, M. J., Kendall, M. J., Barnett, A. H.> ;J Hypertens Suppl. 1985 Dec
• Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.
  Jennings, P. E., Belch, J. J.> ;Metabolism. 2000 Feb
• Vitamin C metabolites and microangiopathy in diabetes mellitus.
  Jennings, P. E., Chirico, S., Jones, A. F., Lunec, J., Barnett, A. H.> ;Diabetes Res. 1987 Nov
• Serum antioxidant activity in diabetes mellitus.
  Jones, A. F., Winkles, J. W., Jennings, P. E., Florkowski, C. M., Lunec, J., Barnett, A. H.> ;Diabetes Res. 1988 Feb
• Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.
  Florkowski, C. M., Richardson, M. R., Le Guen, C., Jennings, P. E., O'Donnell, M. J., Jones, A. F., Lunec, J., Barnett, A. H.> ;Diabetes Res. 1988 Oct
• Microangiopathy as a prognostic indicator in diabetic patients suffering from acute myocardial infarction.
  Brown, H. B., Waugh, N. R., Jennings, P. E.> ;Scott Med J. 1992 Apr
• Sodium transport across erythrocyte membranes in diabetes mellitus.
  Jennings, P. E., Wilkins, M. R., West, M. J., Kendall, M. J., Barnett, A. H.> ;Diabetes Res. 1986 Oct
• Increased diene conjugates in diabetic subjects with microangiopathy.
  Jennings, P. E., Jones, A. F., Florkowski, C. M., Lunec, J., Barnett, A. H.> ;Diabet Med. 1987 Sep 01
• [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
  Jennings, P. E., Belch, J. J.> ;Ter Arkh. 2001
• Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy.
  Dallinger, K. J., Jennings, P. E., Toop, M. J., Gyde, O. H., Barnett, A. H.> ;Diabet Med. 1987 Jan 01
• The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
  Jennings, P. E., McLaren, M., Scott, N. A., Saniabadi, A. R., Belch, J. J.> ;Diabet Med. 1991 Nov
• Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy.
  Jennings, P. E., Nightingale, S., Le Guen, C., Lawson, N., Williamson, J. R., Hoffman, P., Barnett, A. H.> ;Diabet Med. 1990 Jan
• Oxidative stress and diabetic complications in young IDDM patients.
  Elhadd, T. A., Jennings, P. E., Belch, J. J.> ;Diabetes Care. 1997 Aug
• Inhibitory effect of superoxide dismutase on fructosamine assay.
  Jones, A. F., Winkles, J. W., Thornalley, P. J., Lunec, J., Jennings, P. E., Barnett, A. H.> ;Clin Chem. 1987 Jan 01
• Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tis...
  Jennings, P. E., O'Malley, B. P., Griffin, K. E., Northover, B., Rosenthal, F. D.> ;Br Med J (Clin Res Ed). 1984 Dec 15
• Weight gain during the treatment of thyrotoxicosis using conventional thyrostatic treatment.
  Rathi, M. S., Miles, J. N., Jennings, P. E.> ;J Endocrinol Invest. 2008 Jun
• The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.
  Whiting, P. H., Kalansooriya, A., Holbrook, I., Haddad, F., Jennings, P. E.> ;Br J Biomed Sci. 2008 Dec 06
• Join now to see all